Mike Ryan’s Post

#Startups receive priceless mentoring by former #pharma executives in PharmStars’ virtual #acceleratorprogram! 🎓Our Spring 2024 cohort graduate, Chrissa McFarlane, founder and CEO of Patientory, Inc. , shared how PharmStars helped her digital health startup identify and create a clear #pharma value proposition for her company’s sophisticated, digital offering. Chrissa said: “PharmStars commitment to excellence is well received and I couldn't have asked for better feedback and guidance throughout the process in expressing our complicated solution. I am truly grateful to have gone through the program!” 🌟 Don’t miss your chance to get personalized guidance on your pharma business model and value proposition from PharmStars’ Mentor Advisors. You will also have the opportunity to present to and meet with PharmStars’ pharma members. 🚀 Experience PharmStars' commitment to excellence for yourself. Apply to participate by July 15 at www.PharmStars.com! This cohort focuses on “Digital Innovations in Clinical Trials”! #venturecapital #Investment #entrepreneur #Investors #transformation #partnerships #businessdevelopment #bizdev #engagement #financing #funding #biopharma #healthcare #digitaltransformation #digitalinnovation #remotemonitoring #patientexperience #digital #innovation #digitalhealth #virtualtrials #accelerator #datacollection #RemotePatientMonitoring #RPM #datamanagement #VC #clinicaltrials #digitalhealth #startup

📣 Attention #VCs: Do you have a #digitalhealth #startup 🚀 with an #innovation in #ClinicalTrials in your portfolio that wants to do business with #pharma? If they have only a few (or no) pharma clients, the PharmStars accelerator 💥 can help them with product/market fit and provide access to more potential pharma customers.   In addition to learning about how pharma works and getting personalized mentoring, startups in our accelerator program have the unique opportunity to pitch to and meet one-on-one with our pharma members at our private Showcase Event. It's an amazing way to accelerate a startup's pharma business development pipeline. There were 50+ one-on-one, private pharma/startup meetings at our recent Showcase Event in June.   In our #PharmaU program, we coach and educate startups on how to optimize their pharma value proposition to bridge the #PharmaStartupGap -- helping them communicate with and close customers. Even participants with 15+ years of pharma experience gain valuable insights from #PharmaU. PharmaU mentoring is done by seasoned, former pharma executives.   No equity required to participate in our accelerator program- just tuition and a success payment when deals are closed.   Startups of any age/stage welcome, but must have a product or prototype to offer pharma now. Pre-seed through Series B startups have thrived in our program. Areas of focus for this cohort include, but are not limited to: ·     Participant recruitment and retention ·     Trial design ·     Trial execution ·     Remote monitoring and virtual clinical trials ·     Data collection and management ·     Personalized treatment and health equity ·     Medication adherence ·     Patient communication, education, and support ⏰ Hurry! The application deadline is July 15, 2024.  Info and applications: www.PharmStars.com  #venturecapital #Investment #entrepreneur #Investors #transformation #partnerships #businessdevelopment #bizdev #engagement #financing #funding #biopharma #healthcare #digitaltransformation #digitalinnovation, #remotemonitoring #patientexperience #digital #innovation #virtualtrials #accelerator #acceleratorprogram #datacollection #RemotePatientMonitoring #RPM #datamanagement

Europe has become a vibrant hub for health technology 😍 The digital health sector has seen some shifts, with funding and deal volume seeing noticeable reductions in 2023. Investors are showing their support for startups venturing into novel treatment approaches and addressing nonclinical workflow challenges. 💰 In 2023, biotech & pharma emerged as the winner of sector trends. 🔬 Let's explore which investors played a pivotal role in shaping early-stage (Seed - Series A) health-tech deals in Europe in 2023: 1- EQT Group HQ: Amsterdam Health-tech / Life Science deals: 197 2- HTGF | High-Tech Gründerfonds HQ: Bonn Health-tech / Life Science deals: 175 3- Sofinnova Partners HQ: Paris Health-tech / Life Science deals: 121 4- Calm/Storm HQ: Vienna Health-tech / Life Science deals: 76 5- NLC Health Ventures HQ: Amsterdam Health-tech / Life Science deals: 72 6- Mercia Ventures HQ: Henley in Arden Health-tech / Life Science deals: 68 Take a look at the full list of TOP 25 VC funds by following this link 👉 https://lnkd.in/gPEuV5Ju #healthtech #digitalhealth #venturecapital

🚀 We’re excited about next week’s PharmStars Alumni Showcase, featuring our Spring 2023 Cohort which focused on “Digital Innovations in Women’s Health & Health Equity.” The virtual Showcase will take place on July 23, 12-1:30 pm ET! Our digital health startup accelerator continues to support #PharmStarsAlumni in reaching their goals long after they graduate. This is one way we do it! 🎓 Our Alumni Showcases bring together PharmStars startups that have graduated a year ago and our pharma members to hear the startups' updates. This special event is open to select investors and media and will include Q&A between the startups and our pharma champions and experts. 🤝  📈 Pharma members will hear about the cutting-edge work our digital health startups have done since graduation. They have added product features, done pharma deals, raised money, and won prizes! ✨ This is a terrific opportunity for our startups to re-engage, share progress, and receive valuable input from pharma! We have set aside a limited number of seats for the public. Don’t miss this unique opportunity to hear about digital health innovation in women’s health and health equity for pharma.  To attend this invitation-only, virtual event, contact us at info@pharmstars.com. 🌟 To learn more about PharmStars, visit www.PharmStars.com. #womenshealth #healthequity #venturecapital #Investment #entrepreneur #Investors #transformation #partnerships #businessdevelopment #bizdev #engagement #financing #funding #biopharma #healthcare #pharma #digitaltransformation #digitalinnovation #accelerator #acceleratorprogram #VC #pharmaceutical #biotech #HIT #medtech #healthtech #HealthIT #digitalhealth #startup  

PharmStars is the go-to #accelerator for startups looking to engage #pharma as clients. “PharmStars was one of the best and most practically useful of all the accelerators we've participated in,” said #PharmStarsAlumni, Nader Alaghband, CEO of Ampersand Health. Why? Because of our: 🎯 Personalized mentoring: Tailored guidance for your startup's success by a small team of former pharma executives (no big, volunteer network of mentors!) 🎯 Pharma curriculum: Comprehensive curriculum about how pharma works and how to engage them in deals 🎯 Pharma Fireside Chats: Hear from and ask questions of pharma champions from our members in an intimate setting 🎯 Showcase Event: In-person pitch presentation followed by private meetings with our pharma members PharmStars 🚀 is now accepting applications for our Fall 2024 cohort, focused on #startups with digital #innovations in #ClinicalTrials. 📢 📢 📢 Apply on our website www. PharmStars.com by July 15, 2024 #venturecapital #Investment #entrepreneur #Investors #transformation #partnerships #businessdevelopment #bizdev #engagement #financing #funding #biopharma #healthcare #digitaltransformation #digitalinnovation, #remotemonitoring #patientexperience #digital #innovation #virtualtrials #acceleratorprogram #datacollection #RemotePatientMonitoring #RPM #datamanagement #VC #clinicaltrials #digitalhealth #startup #pharmaceutical #biotech #HIT #medtech #healthtech #HealthIT

🙋♀️ Do you believe in the promise of #DigitalHealth to improve #patient outcomes and #reducecost in #drugdevelopment? 💊 📲 Do you want to know how to bridge the gap between #pharma and digital #health #startups working on these innovative solutions? 💥 PharmStars knows how to bring startups and #biopharma together to bridge the pharma/startup gap! Our 10-week #accelerator program is designed to prepare startups for more productive engagements with pharma, teaching them what they need to know. 🚀 🌏 PharmStars is a virtual #accelerator, open to digital health startups from around the world because healthcare #innovation has no bounds 🙌 and happens anywhere. Our Fall accelerator will focus on "Digital Innovations in #ClinicalTrials." Learn more and apply (deadline is July 15!) 👉 👉 👉 www.PharmStars.com #transformation #healthcare #biotech #biopharma #entrepreneurs #digitaltransformation #digitalinnovation, #remotemonitoring #patientexperience #clinicaltrials #digital #innovation #digitalhealth #startups #virtualtrials #accelerator #acceleratorprogram #datacollection #RemotePatientMonitoring #RPM #datamanagement

🌟 Mastering the Funding Journey in MedTech Startups 🌟 Securing funding in the MedTech world is a pivotal challenge that can define the future of healthcare innovation. As industry pioneers navigate this journey, understanding the nuances of investment, regulatory strategy, and quality management becomes crucial. Here's a blend of wisdom and strategy for those at the crossroads of funding their MedTech dreams. The 'Dead Zone' in Funding Navigating the funding landscape requires a keen understanding of the 'Dead Zone' — a funding gap typically between $2–5 million. Identifying the right sources and crafting precise funding requests can make all the difference. It's about aligning your needs with the right investors who share your vision for healthcare innovation. Regulatory Strategy as a Beacon for Investors A clear and well-planned regulatory strategy does more than comply; it inspires confidence. Initiatives like FDA pre-submissions showcase not just the potential of your technology but also your team's ability to navigate complex regulatory landscapes. It's a testament to your foresight and preparedness, qualities that resonate deeply with potential investors. Embracing Quality Early On Integrating a quality management system (QMS) and design controls from the outset isn't just about meeting standards; it's about building trust. A 'bootstrap' approach to your QMS demonstrates prudent resource management and a commitment to excellence. It signals to investors that you're building a foundation for long-term success and reliability. The Impact of Clinical Validation and Market Understanding Understanding your market and the clinical impact of your technology is crucial. Demonstrating this depth of knowledge and a clear path to reimbursement positions your technology as not just viable but vital. It's about showing a future where your innovation is not just present but is making a significant difference in healthcare. The Human Factor in Innovation Behind every successful startup is a team that believes in its mission. Showcasing a team that's technically skilled and deeply understands the market, regulatory requirements, and patient needs is invaluable. Their adaptability, insight, and execution are what will ultimately bring your technology from concept to reality. Conclusion: Navigating Towards Success The path to securing funding in MedTech is intricate but far from insurmountable. With the right understanding of the investment landscape, a solid regulatory strategy, a commitment to quality, and a deep understanding of the market, startups can turn potential hurdles into opportunities for growth and innovation. In the world of MedTech, thorough preparation and a clear vision are your guides to turning innovative ideas into life-changing realities. #MedTech #StartupFunding #RegulatoryStrategy #QualityManagement #ClinicalValidation #HealthcareInnovation #NeuroMarqConsulting

🌱Navigate Funding Challenges with Confidence: Key Insights for MedTech Startups As you shape the future of healthcare through your early-stage medical technology startup, funding can be both exciting and demanding. Amid a 40% drop in early investment for biotech startups in 2023, according to HSBC, a strategic funding approach aligned with your vision is vital. Here are some key insights to fuel your funding strategy: 📎Government Grants: Government grants offer non-repayable funds, providing a solid initial boost. However, be cautious not to let grant terms dictate your project. While they're not usually recurring, they can be a fantastic stepping stone. 🌱Early Seed Funding: Engage angel investors who see your vision and understand the market demand for your product. Showcase how your innovation fills a void, addressing unmet needs and setting you apart from competitors. 📎Venture Capital Funding: If your ambitions require substantial investment, VC funding may be the path. Seek specialized VCs in your field who share your vision. Clearly articulate your value proposition, market entry strategy, and assemble a strong management team. 📎Alternative Funding Sources: Beyond traditional avenues, explore family offices, angel groups, non-dilutive options, and low-cost venture debt. Your location isn't a limit; think globally to find the right fit. 💡 Increasing Investor Confidence: FDA's Total Product Life Cycle Advisory Program (TAP) offers a faster route to regulatory approval. FDA endorsement not only boosts investor confidence but also aligns your breakthrough with evolving health needs. 🌍 Global Opportunities: Look beyond borders—consider international markets with vast patient base and investment potential. Partnering or entering such markets can provide fresh avenues for growth. 🌱 Remember, each funding source shapes your journey uniquely. Building relationships with partners who align with your goals is as crucial as securing funds. For tailored guidance on your funding journey, Kreivo Health is here to support you. Contact us at contact@kreivohealth.com to explore the best and most suitable path for your startup. #medtechinnovation #healthcareconsulting #fundingsolutions #fundingoptions #medtechinsights #healthcarecollaboration #kreivohealth

#Ireland-based #FeelTect secures €1.5M in #funding. Current owners were joined by #investors from other Halo Business Angel Network (HBAN) syndicates, including Irrus Investments, MedTech Syndicate, and Boole Investment Syndicate, in addition to CAJU Venture Partners. The WDC also increased their current investment in the company. The new round’s €1.5 million funding comes after a previous €1.2 million Seed round that concluded in 2022 and was backed by #prominent #healthcare investors as well as state organisations like Enterprise Ireland, Dogpatch Labs, and the WDC. With the funding, the company wants to expand its #workforce by adding people to positions in R&D, manufacturing, project management, clinical affairs, and commercial development. It also hopes to establish more #clinical partnerships, expand its network of strategic #alliances, and accelerate the commercialization of its wound treatment monitoring technology. Ireland’s FeelTect is a start-up company focused on linked health. Before establishing the business in May 2019, we started our #adventure at National University of #Ireland, Galway (NUIG) through the esteemed #BioInnovate Ireland course. FeelTect IRRUS INVESTMENTS MedTech Syndicates Boole Investments CAJU Venture Partners Dogpatch Labs Andrew Cameron Darren Burke To share your startup story write us on - contact@startuprise.co.uk #feeltect #funding #eustartup

Yesterday, I had the privilege of attending a masterclass at Jumar Bioincubator that left me truly inspired. The session, titled "You've secured funding, what next?" featured a distinguished panel of thought leaders in the biotech industry: Chris Smith, Partner at Brandon Capital; Tara Speranza, Investment Analyst at Tenmile; Larisa Chisholm GAICD, COO of Denteric; and Christos Papadimitriou, CEO and Managing Director of Tessara Therapeutics.   Amidst the wealth of knowledge shared, Chris Smith's insights truly resonate with me. Here are the key points I took away:   🚀 Celebrate Every Milestone: The biotech startup journey is a marathon. Celebrate every win along the way. Each milestone achieved is a testament to your progress.   💰 Understanding Time Value of Money: Managing resources wisely and understanding the time value of money can make or break your venture.   🏃 Keep the Momentum: Once you secure funding, seize the momentum. Run fast and purposefully with the capital you've raised. Speed is often a competitive advantage in biotech.   🎯 Focus on Value Delivery: Concentrate your efforts on activities that genuinely deliver value. Efficient resource allocation is key to success.   📢 Effective Communication: Investors appreciate transparency. Communicate regularly and openly, sharing both good and bad news. Trust is built on open dialogue.   📅 Planning & Milestones: Planning is the bedrock of success. Pay close attention to milestones, and ensure you have a clear roadmap. Many companies falter due to insufficient planning and missed milestones.   📊 Benchmarking Excellence: Benchmarking against the best in the industry is a powerful tool. Don't be afraid to measure your progress against global standards.   🔍 First Venture vs. Second: The first venture in biotech often paves the way for the second, which is statistically more likely to succeed. Learn from each experience.   Many thanks to Dr Katja Beitat and Camille Shanahan for making this enlightening event possible. The knowledge shared during this masterclass is a compass guiding us through the complexities of the biotech landscape. Let's harness these insights as we collaborate to push the boundaries of science and innovation together. 💡🔍 #biotech #capitalraising #biotechstartup #fundingstrategy #innovationjourney #BioincubatorInsights